Skip to main content
EVO
NASDAQ Life Sciences

JPMorgan Reduces Stake in Evotec SE, Goldman Sachs Increases Holdings

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$3.18
Mkt Cap
$1.137B
52W Low
$2.84
52W High
$4.8
Market data snapshot near publication time

summarizeSummary

JPMorgan Chase & Co. significantly reduced its total voting rights in Evotec SE from 5.62% to 3.64%, while The Goldman Sachs Group, Inc. increased its stake from 4.63% to 5.27%.


check_boxKey Events

  • JPMorgan Reduces Stake

    JPMorgan Chase & Co. decreased its total voting rights in Evotec SE from 5.62% to 3.64%, crossing the 3% threshold on December 24, 2025. This reduction represents approximately $11.2 million in shares.

  • Goldman Sachs Increases Holdings

    The Goldman Sachs Group, Inc. increased its total voting rights in Evotec SE from 4.63% to 5.27%, crossing the 5% threshold on December 23, 2025. This increase represents approximately $3.6 million in shares.

  • Institutional Rebalancing

    The changes reflect significant adjustments in the positions of two major financial institutions, indicating a shift in their investment strategies regarding Evotec SE.


auto_awesomeAnalysis

This 6-K filing indicates notable shifts in institutional ownership for Evotec SE. JPMorgan Chase & Co.'s reduction of its total voting rights by nearly 2 percentage points, representing approximately $11.2 million in shares, suggests a re-evaluation of its position. Conversely, Goldman Sachs's increase in its total holdings, though smaller in magnitude, shows continued interest. While institutional rebalancing is common, a significant reduction by a major financial institution like JPMorgan could be interpreted as a cautious signal, potentially outweighing the smaller increase by Goldman Sachs. Investors should monitor future institutional filings for further trends.

At the time of this filing, EVO was trading at $3.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $2.84 to $4.80. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed EVO - Latest Insights

EVO
Apr 24, 2026, 6:03 AM EDT
Filing Type: 6-K
Importance Score:
7
EVO
Apr 08, 2026, 11:56 AM EDT
Filing Type: 6-K
Importance Score:
8
EVO
Apr 08, 2026, 11:52 AM EDT
Filing Type: 20-F
Importance Score:
8
EVO
Apr 07, 2026, 12:44 PM EDT
Filing Type: 6-K
Importance Score:
9
EVO
Apr 06, 2026, 12:56 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
EVO
Mar 30, 2026, 8:29 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
EVO
Mar 10, 2026, 6:00 AM EDT
Filing Type: 6-K
Importance Score:
9
EVO
Jan 16, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
7
EVO
Jan 13, 2026, 7:32 AM EST
Filing Type: 6-K
Importance Score:
8
EVO
Jan 08, 2026, 10:09 AM EST
Filing Type: 6-K
Importance Score:
7